Archives

Exploring the Kidney-Brain Connection: Anxiety & Depression in Chronic Kidney Disease
About This Event
Exploring the Kidney-Brain Connection: Anxiety & Depression in Chronic Kidney Disease
Objectives
- Define anxiety and depression, and discuss prevalence among chronic kidney disease (CKD) patients
- Identify potential risk factors and mechanisms of both anxiety and depression in CKD
- Recognize overlapping symptomatology, and examine the cycle among anxiety, depression, and CKD and associated poor outcomes
- Address challenges in managing anxiety and depression in patients with CKD
Angelina’s
Staten Island, New York 10307 United States + Google Map
Featuring

Max Hyams, PharmD, RPh
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Max Hyams, PharmD, RPh, is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization (OPDC) covering New Jersey. He earned his Doctorate of Pharmacy from Albany College of Pharmacy and Health Sciences in Albany, New York. Prior to joining Otsuka, he was a Global Pharmacovigilance Case Processor in Specialty Medicine at Bayer, working closely with colleagues in Brazil and Germany. Prior to that, he was a Pharmacy Manager for CVS, working in the highest volume, 24-hour stores in Northern New Jersey, and has experience working for an independent pharmacy specializing in fertility medications. He is currently licensed as a pharmacist in New Jersey and resides in Hoboken, New Jersey.

Yasmin Togun, PhD
Psychologist with a focus on Pediatric Psychology and Health Service Psychology. Prior to joining Otsuka, she practiced as an Attending Psychologist on the Psychiatry Consultation Liaison Service at Boston Children’s Hospital and a Clinical Instructor of Psychology at Harvard Medical School.
Max Hyams, PharmD, RPh and Yasmin Togun, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)